Metraipolis › archive › dc_7fdd85b287e2

Oncologic Outcomes and Safety of Neoadjuvant Treatment with Anthracyclines Versus Anthracycline-Free Regimens in HER2-Positive Early Breast Cancer in a… — Europe PMC PMID:41097717

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41097717
DOI
10.3390/cancers17193190
License (as archived)
solo-consultazione
Archived
2026-11-09T16:47:06.785Z
SHA-256 of the archived text
f5bddded194010bf1553db2423b2c119820d5bc3b47ac75684b1b34f6b767756
Stable URL of this page
https://metraipolis.com/documento/dc_7fdd85b287e2

How to cite

Oncologic Outcomes and Safety of Neoadjuvant Treatment with Anthracyclines Versus Anthracycline-Free Regimens in HER2-Positive Early Breast Cancer in a… — Europe PMC PMID:41097717 — Europe PMC (en), https://europepmc.org/article/MED/41097717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7fdd85b287e2 (Metraipolis archive dc_7fdd85b287e2, sha256 f5bddded194010bf1553db2423b2c119820d5bc3b47ac75684b1b34f6b767756)
BibTeX
@misc{dc7fdd85b287e2,
  title = {Oncologic Outcomes and Safety of Neoadjuvant Treatment with Anthracyclines Versus Anthracycline-Free Regimens in HER2-Positive Early Breast Cancer in a… — Europe PMC PMID:41097717},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41097717},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7fdd85b287e2; sha256 f5bddded194010bf1553db2423b2c119820d5bc3b47ac75684b1b34f6b767756},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41097717. Agents can read the archived copy with the MCP tool read_document.